First Allied Advisory Services’s ImmunoCellular Therapeutics, Ltd. IMUC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-40,000
| Closed | -$8K | – | 1242 |
|
|
2018
Q3 | $8K | Hold |
40,000
| – | – | ﹤0.01% | 1176 |
|
|
2018
Q2 | $10K | Hold |
40,000
| – | – | ﹤0.01% | 1143 |
|
|
2018
Q1 | $10K | Buy |
+40,000
| New | +$10K | ﹤0.01% | 1161 |
|
|
2015
Q4 | – | Sell |
-1,125
| Closed | -$19K | – | 1180 |
|
|
2015
Q3 | $19K | Hold |
1,125
| – | – | ﹤0.01% | 1039 |
|
|
2015
Q2 | $21K | Hold |
1,125
| – | – | ﹤0.01% | 1133 |
|
|
2015
Q1 | $22K | Hold |
1,125
| – | – | ﹤0.01% | 1060 |
|
|
2014
Q4 | $33K | Hold |
1,125
| – | – | ﹤0.01% | 1014 |
|
|
2014
Q3 | $40K | Hold |
1,125
| – | – | ﹤0.01% | 1015 |
|
|
2014
Q2 | $50K | Hold |
1,125
| – | – | ﹤0.01% | 964 |
|
|
2014
Q1 | $55K | Hold |
1,125
| – | – | ﹤0.01% | 982 |
|
|
2013
Q4 | $42K | Buy |
1,125
+125
| +13% | +$4.67K | ﹤0.01% | 931 |
|
|
2013
Q3 | $103K | Hold |
1,000
| – | – | 0.01% | 951 |
|
|
2013
Q2 | $78K | Buy |
+1,000
| New | +$78K | 0.01% | 916 |
|